# Avançsa

> Avançsa is a VC fund backing Manufacturing, Information Technology and Software. See 16 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 16
- Last investment: Jun 2026
- Lead investor: 69%
- Last updated: Aug 2026

Avançsa is a VC fund focused on Manufacturing and Information Technology. Private equity arm of Generalitat de Catalunya .

## Round sizes

| Stage | Round size |
| --- | --- |
| Debt Financing | $485k–$2.2M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 3 | 19% |
| Information Technology | 3 | 19% |
| Software | 2 | 13% |
| Clean Energy | 2 | 13% |
| Neuroscience | 2 | 13% |

41 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Debt Financing | 9 | 56% |
| Seed | 1 | 6% |
| Series A | 1 | 6% |
| Series B | 1 | 6% |
| Funding Round | 1 | 6% |

8 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Floox | Floox llega para diseñar, desarrollar y fabricar puntos de carga rápida en corriente continua para vehículos eléctricos. Somos un equipo de más 120 personas trabajando para revolucionar la movilidad eléctrica y así crear un mundo más efectivo, fácil y sostenible. | $2.3M | Venture - Series Unknown | Jun 17, 2026 |  |
| INGALSA | INGALSA specializing in hot-dip galvanizing of steel parts and fasteners. | $813.7K | Debt Financing | Nov 14, 2025 |  |
| NEOS Surgery | NEOS Surgery is a technology-based company dedicated to the creation of medical devices for neurosurgery. The company focuses on the R&D, design, production, and commercialization of innovative implants in the fields of cranial and spinal surgery. Our products aim at occupying the niches of the current market by responding to the needs of bothpatients and neurosurgeons.NEOS is a certified producer of medical devices and implements the complete ISO 9001: 2008 and ISO 13485: 2003 / AC: 2007 quality systems.NEOS Surgery’s mission is to capture the demands of the Neurosurgery market in order to develop, manufacture, certify and commercialize new devices, which create company value and foster a high added-value industry. | $582.3K | Debt Financing | Oct 15, 2025 |  |
| X1 Wind | X1 Wind is a disruptive floating platform developing a floating wind platform for deep waters. The platform has redesigned floating wind platforms to reduce costs by 50percent and weight 80percent while expanding the operation depth range in comparison to other floating solutions. It has less active systems than current designs and can be fullyassembled at the port and then installed using a small tug boat.X1 Wind helps to achieve a radical weight reduction in floating wind structures to current semi-submersible and spar systems. It was founded in 2017 and is based in Barcelona, Spain. | $641.6K | Convertible Note | Jul 14, 2025 |  |
| Nearby Computing | NearbyComputing commercializes NearbyOne, an Edge IT fabrics orchestration platform that seamlessly manages the lifecycle of infrastructure, the VNFs and the applications, controlling their deployment and associated resources. NearbyOne addresses all these orchestration issues in a holistic and intertwined way. Applications and VNFs provided bythird party ISVs are onboarded to create a rich ecosystem of pre-integrated services, that get deployed in one-click. Service assurance and KPI monitoring are natively integrated into the platform to automatically control service SLAs. Infratructure, Network, Apps and KPIs are managed from a single pane of glass, and smart placement and configuration policies dynamically adjust service levels. | $559.3K | Debt Financing | May 13, 2025 |  |
| INBRAIN Neuroelectronics | INBRAIN Neuroelectronics is pioneering real time precision neurology with the world’s first graphene-based brain-computer interface (BCI) therapeutics platform. Our technology combines precise BCI decoding with micrometric modulation to deliver adaptive, personalized treatments for conditions such as Parkinson’s disease, epilepsy, and strokerehabilitation. By providing continuous real-time monitoring and autonomous therapy adjustments, our AI-driven platform maximizes therapeutic outcomes while minimizing side effects. Through strategic collaborations, including with Merck KGAa and our subsidiary INNERVIA Bioelectronics, we are extending our innovative solutions to peripheral nerve and systemic disease applications, unlocking the potential of neurotechnology and bioelectronics. For more information, visit www.inbrain-neuroelectronics.com and follow us on LinkedIn. | $49.8M | Series B | Oct 29, 2024 |  |
| Qilimanjaro Quantum Tech | Qilimanjaro is a quantum computing company based in Barcelona, making quantum useful today. Founded in 2019, we develop full-stack quantum computers based on fluxonium analog qubits, a novel architecture that bypasses the need for error correction, enabling faster, more scalable solutions. Our approach is application-first: analog quantum computingoffers near-term advantages and optimality for highly relevant problems, especially in simulation, optimization, and AI, where digital QPUs fall short. We follow a dual strategy to democratize access to quantum computing:• Via our Quantum-as-a-Service (QaaS) platform, users can remotely access our hybrid quantum data centers, combining analog and digital QPUs with classical HPC. • For research institutions and HPC centers, we provide on-premise quantum deployments, offering flexibility, control, and co-design.By aligning quantum hardware with real-world needs, Qilimanjaro is building a future where quantum computing is practical, scalable, and ready to deliver value - not in decades, but now. | $1.6M | Debt Financing | Jul 18, 2024 |  |
| Ocean Ecostructures | Ocean Ecostructures is the developer of a biodiversity regeneration program that will assist businesses and governments in transitioning to a blue economy. | $540.6K | Debt Financing | Jun 12, 2024 |  |
| WIVI Vision | visual+cognitive enhancement | $4.3M | Series A | Feb 19, 2024 |  |
| Zymvol Biomodeling | Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations. | $761.5K | Debt Financing | Jan 16, 2024 |  |

10 of 16 investments shown.

## Co-investors
- [Adara Ventures](https://shizune.co/investors/profile/adara-venture-partners) — VC Fund, 1 deal together
- [Aliath Bioventures](https://shizune.co/investors/profile/aliath-bioventures) — VC Fund, 1 deal together
- [Asabys Partners](https://shizune.co/investors/profile/asabys-partners) — VC Fund, 1 deal together
- [Santander](https://shizune.co/investors/profile/banco-santander) — VC Fund, 1 deal together
- [Clidrive](https://shizune.co/investors/profile/banco-santander-6f7d) — VC Fund, 1 deal together
- [BBVA Spark](https://shizune.co/investors/profile/bbva-spark) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund
- [Shell Ventures](https://shizune.co/investors/profile/shell-technology-ventures) — VC Fund

### Similar stage
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Development Bank of Wales](https://shizune.co/investors/profile/development-bank-of-wales) — VC Fund
- [The FSE Group](https://shizune.co/investors/profile/finance-south-east) — VC Fund

### Similar country
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Inveready](https://shizune.co/investors/profile/inveready-technology-investment-group) — VC Fund
- [Angels Capital](https://shizune.co/investors/profile/angels-capital) — VC Fund

## Featured in investor lists
- [Climate Investors in Spain](https://shizune.co/investors/climate-investors-spain)
- [Climate VC Funds in Spain](https://shizune.co/investors/climate-vc-funds-spain)
- [Manufacturing Investors in Spain](https://shizune.co/investors/manufacturing-investors-spain)
- [Manufacturing VC Funds in Spain](https://shizune.co/investors/manufacturing-vc-funds-spain)
- [Energy Investors in Spain](https://shizune.co/investors/energy-investors-spain)
- [Sustainability VC Funds in Spain](https://shizune.co/investors/sustainability-vc-funds-spain)

## FAQ

### What does Avançsa invest in?

Avançsa invests primarily in Manufacturing, Information Technology and Software startups, most often at Debt Financing and Seed stage. Most of the 16 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Avançsa's check size?

Avançsa typically joins rounds of $485k–$2.2M at Debt Financing. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Avançsa participates in.

### When did Avançsa last invest?

The most recent investment recorded for Avançsa closed in Jun 2026. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co